Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2011
Antiplasmodial and antitumor activity of dihydroartemisinin analogs derived via the aza-Michael addition reaction
Tzu-Shean Feng, Eric M Guantai, Margo J Nell, et al.
Biochemical Pharmacology
|
May 21, 2011
Effects of highly active novel artemisinin-chloroquinoline hybrid compounds on β-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum
Tzu-Shean Feng, Eric M Guantai, Margo Nell, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 28, 2011
Antiplasmodial and cytotoxicity evaluation of 3-functionalized 2-azetidinone derivatives
Pardeep Singh, Shaveta Sachdeva, Raghu Raj, et al.
Journal of Medicinal Chemistry
|
October 5, 2011
Novel orally active antimalarial thiazoles
Diego González Cabrera, Frederic Douelle, Tzu-Shean Feng, et al.
Bioorganic & Medicinal Chemistry
|
November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization
Candice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
Journal of Medicinal Chemistry
|
November 30, 2012
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines
Diego González Cabrera, Frederic Douelle, Yassir Younis, et al.
Journal of Medicinal Chemistry
|
January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agents
Diego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Journal of Medicinal Chemistry
|
March 7, 2012
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential
Yassir Younis, Frederic Douelle, Tzu-Shean Feng, et al.
Journal of Medicinal Chemistry
|
August 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic Agents
Simon R Stockwell, Duncan E Scott, Gerhard Fischer, et al.
ACS Infectious Diseases
|
March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization
Dinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2011
Antiplasmodial and antitumor activity of dihydroartemisinin analogs derived via the aza-Michael addition reaction
Tzu-Shean Feng, Eric M Guantai, Margo J Nell, et al.
Biochemical Pharmacology
|
May 21, 2011
Effects of highly active novel artemisinin-chloroquinoline hybrid compounds on β-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum
Tzu-Shean Feng, Eric M Guantai, Margo Nell, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 28, 2011
Antiplasmodial and cytotoxicity evaluation of 3-functionalized 2-azetidinone derivatives
Pardeep Singh, Shaveta Sachdeva, Raghu Raj, et al.
Journal of Medicinal Chemistry
|
October 5, 2011
Novel orally active antimalarial thiazoles
Diego González Cabrera, Frederic Douelle, Tzu-Shean Feng, et al.
Bioorganic & Medicinal Chemistry
|
November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization
Candice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
Journal of Medicinal Chemistry
|
November 30, 2012
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines
Diego González Cabrera, Frederic Douelle, Yassir Younis, et al.
Journal of Medicinal Chemistry
|
January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agents
Diego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Journal of Medicinal Chemistry
|
March 7, 2012
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential
Yassir Younis, Frederic Douelle, Tzu-Shean Feng, et al.
Journal of Medicinal Chemistry
|
August 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic Agents
Simon R Stockwell, Duncan E Scott, Gerhard Fischer, et al.
ACS Infectious Diseases
|
March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization
Dinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Page
of 1